©2019 by FathomX

A better world for women through better breast health

ABOUT US

FathomX is a Medtech spinoff from the National University of Singapore and National University Health System that aims to incorporate artificial intelligence into healthcare technologies

 
 

FathomMammo

Fathommammo is an AI Assistant developed by FathomX that analyses mammograms to assist in early detection of breast cancer. Through the use of deep learning technologies and clinically validated parameters, the assistant is able to detect abnormal lesions, estimate one's risk of developing breast cancer and automatically generate a radiology report for use by clinicians. The AI technology improves both the efficiency and accuracy of existing methods, hence reducing the burden on clinicians on the ground.

What is FathomMammo

Cancer Risk

Estimation

Estimation of the risk of cancer through medical imaging and medical history records analysis

Features

Lesion Heatmap Generation

Heatmap generation of abnormal lesions for analysis and follow up action

Automatic Report

Generation

Automatically generated radiology report based on clinical guidelines

 
 

Video

 

Meet The Team

du hao.PNG

Du Hao

Co-Founder

Engineering & Technology

mayank_edited.png

Mayank Gurnani

Venture Advisor

Jeff.jpg

Jeff Weisel

Commercial Advisor

In the news

 
Dr Hartman.png

Dr Mikael Hartman

Co-Founder 

Clinical Lead

Capture_edited.png

Dr Feng Meng Ling

Co-Founder

Technical Lead

Amos_edited.png

Amos Heng

Co-Founder 

Business Development

 

Research/Commercialisation Partners

NUS Research Spin-off
NUH Clinical Trials
KKH Clinical Trials
Health Services Research Grant
SMART Innovation Grant
Test
NUS GRIP Funding
Show More

Contact Us

12 Science Drive 2, #10-01

86613625